Additionally, about 80% of RCC patients have VHL gene mutations [37], which upregulates the hypoxia-inducible factor (HIF) and produces a pseudo-hypoxic state, which in turn increases glycolysis [38]. This evidence concerns the gene VHL and renal cell carcinoma.